NUTRIAGAVES GROUP / NUTRITION INNOVATION

APPLICATION 09 / GLP-1-ALIGNED NUTRITION

GLP-1 &
Olifructine™.

Formulating the Next Generation
of Nutrient-Focused Foods.

Discover how organic agave fructans can support fibre-enriched formulations, texture development and nutritional product innovation for evolving consumer needs.

Olifructine organic agave fructans

ORGANIC AGAVE FRUCTANS

Fibre · Texture · Innovation

INGREDIENT

Olifructine™

INGREDIENT FAMILY

Branched Fructans

DEVELOPMENT FOCUS

Fibre & Mouthfeel

THE FORMULATION CHALLENGE

Nutrition Without
Compromising Experience.

Nutritional product development increasingly explores food formats that combine dietary fibre, protein and satisfying sensory characteristics.

Reformulating foods and beverages to modify their nutritional composition can affect body, mouthfeel, sweetness perception and flavour balance. These changes may be especially challenging in protein-rich formulations.

Olifructine™ Organic Agave Fructans provide a soluble dietary fibre ingredient for manufacturers evaluating these formulation needs. Product-specific testing remains essential.

NUTRITIONAL PRODUCT DEVELOPMENT

Three Priorities.
One Ingredient Strategy.

01 / FIBRE

Nutritional Enrichment

Incorporate soluble agave fructans when developing products with defined dietary fibre targets.

02 / TEXTURE

Sensory Balance

Evaluate mouthfeel, body, creaminess and ingredient interactions in reformulated foods and beverages.

03 / INNOVATION

Digestive Science

Explore the relationship between fermentable dietary fibres, gut microbiota and emerging areas of metabolic nutrition research.

THE SCIENCE / MOLECULAR ARCHITECTURE

The Distinctive Structure
of Agave Fructans.

The official Olifructine™ brief describes naturally branched agave fructans with a broad degree-of-polymerisation range, approximately DP 2–50+. This molecular architecture informs ongoing research into their fermentation characteristics and technological applications.

BRANCHED ARCHITECTURE

Structural Diversity

Unlike the predominantly linear structure associated with conventional chicory inulin, agave fructans include branching patterns relevant to their physicochemical properties.

BRIEF REFERENCE

DP 2–50+

Approximate described range

FERMENTATION RESEARCH

Microbial Utilisation

The brief proposes a gradual fermentation profile for branched agave fructans and describes the potential generation of short-chain fatty acids (SCFA) along the colon.

The extent, timing and physiological significance of these processes depend on ingredient composition, experimental conditions and the individual host.

EMERGING SCIENCE / GUT-METABOLIC SIGNALLING

Exploring the Gut–Satiety
Research Pathway.

The supplied brief connects agave fructan fermentation with microbial SCFA production and research into intestinal signalling pathways. GLP-1 is one hormone investigated in this wider field of gut-metabolic science. This conceptual pathway should not be interpreted as a demonstrated clinical outcome for Olifructine™.

STAGE 01

Agave Fructans

Branched soluble fibre enters the digestive system.

STAGE 02

Gut Fermentation

Microbial utilisation is evaluated as part of the proposed mechanism.

STAGE 03

SCFA Generation

Fermentation metabolites are studied for their biological relevance.

RESEARCH AREA

Gut Signalling

Potential relationships with L-cell activity, GLP-1 and satiety are topics for scientific investigation.

Conceptual research pathway only. No demonstrated treatment effect, weight-loss outcome or clinically meaningful GLP-1 response is claimed for Olifructine™.

R&D CONSIDERATIONS

Formulation Science
Beyond the Ingredient.

The official brief discusses fibre content, microbiota research, fermentation and digestive tolerance. The following parameters offer a framework for professional evaluation; they are not universal recommended doses or substantiated consumer claims.

01 / FIBRE CONTENT

Nutrition Targets

Determine analytical fibre contribution, serving size and eligibility for local fibre-related labelling.

02 / MICROBIOTA

Prebiotic Research

Assess microbial utilisation and relevant populations in scientifically appropriate studies.

03 / TOLERANCE

Digestive Evaluation

Evaluate ingredient tolerance and gastrointestinal responses using suitable protocols and target populations.

FOOD & BEVERAGE INNOVATION

One Ingredient.
Multiple Product Formats.

The official brief identifies seven food and beverage categories where Olifructine™ may be evaluated for fibre enrichment, texture and sensory formulation objectives.

Snacks

Texture and firmness evaluation.

Bakery

Softness and mouthfeel considerations.

Powder & RTD Beverages

Body, solubility and sensory balance.

Frozen Desserts

Creaminess and texture development.

Dairy Products

Body, texture and fibre incorporation.

Spreads

Spreadability and consistency.

Confectionery

Texture and flavour-profile evaluation.

PRACTICAL FORMULATION

Nutrition Targets.
Sensory Expectations.

Developing fibre-enriched foods and beverages is not only a nutritional challenge. Product acceptance also depends on texture, consistency, appearance and taste.

Olifructine™ can be assessed within integrated formulations where protein systems, sweeteners and dietary fibre must perform together.

EVALUATION CHECKLIST

Soluble Fibre Contribution
Protein System Compatibility
Texture & Mouthfeel
Sweetener Off-Notes
Processing & Shelf Life

SCIENTIFIC DOCUMENTATION

Research-Informed
Ingredient Development.

The official Olifructine™ GLP-1 formulation brief presents a conceptual diagram of branched molecular architecture and a comparative fermentation-kinetics illustration. These visuals will be incorporated after uploading the approved artwork to Shopify and reviewing their scientific context and references.

SCIENTIFIC VISUAL 01

Branched Molecular Architecture

Official illustration of agave fructan branching and the proposed gut fermentation pathway.

SCIENTIFIC VISUAL 02

Fermentation Kinetics

Official conceptual comparison of linear chicory inulin and branched agave fructans across gut regions.

NUTRIAGAVES GROUP / R&D COLLABORATION

Your Next Formulation
Starts with Research.

Connect with NutriAgaves Group to explore ingredient specifications, formulation support and technical documentation for nutrient-focused food and beverage development.

CONTACT OUR R&D TEAM →

INGREDIENT RESOURCES

Explore Olifructine™.

Learn more about our organic agave fructans and access the NutriAgaves Group ingredient catalogue.

OLIFRUCTINE™ ↗ CATALOGUE ↗

Information intended exclusively for professional food and beverage research and formulation audiences. GLP-1-aligned product development is a nutritional formulation concept and does not indicate a pharmacological effect. Olifructine™ is not a GLP-1 receptor agonist or a medicine. No claims of weight loss, appetite suppression, increased GLP-1 secretion or therapeutic benefit are made for the ingredient. Fibre claims, prebiotic activity, digestive tolerance, fermentation patterns and health-related statements require suitable evidence and applicable regulatory approval or review.